申请人:ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL CO., LTD.
公开号:US11286248B2
公开(公告)日:2022-03-29
Disclosed are a compound as shown in formula (I), and an isomer thereof or a pharmaceutically acceptable salt thereof, and involved is the use thereof in the preparation of drugs for treating FGFR-associated diseases.
公开了一种如式(I)所示的化合物及其异构体或其药学上可接受的盐,并涉及其在制备治疗 FGFR 相关疾病的药物中的用途。